Carolina Urological Research Center

Myrtle Beach, South Carolina 29579

0 studies enrolling now · 5 studies all time

What they study most

Biochemically Recurrent Prostate Cancer, Cancer, Metastatic Hormone-sensitive Prostate Cancer, Prostate Cancer, Prostatic Cancer, Castration-Resistant

Studies at this site

• Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer — Running, not enrolling
• A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies — Running, not enrolling
• A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study. — Running, not enrolling
• Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC) — Stopped early
• PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study — Stopped early